HER-2 PROTEIN OVEREXPRESSION
Clinical trials for HER-2 PROTEIN OVEREXPRESSION explained in plain language.
Never miss a new study
Get alerted when new HER-2 PROTEIN OVEREXPRESSION trials appear
Sign up with your email to follow new studies for HER-2 PROTEIN OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells join forces with checkpoint drugs to fight hard-to-treat sarcomas
Disease control Recruiting nowThis early-phase study tests whether giving specially engineered immune cells (HER2-CAR T cells) together with an immune checkpoint inhibitor (pembrolizumab or nivolumab) is safe and can help people with advanced sarcoma. About 25 participants will receive chemotherapy to prepare…
Matched conditions: HER-2 PROTEIN OVEREXPRESSION
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
New drug shows promise for Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis study tests a drug called zanidatamab in people with advanced solid tumors that have high levels of HER2 protein. Participants must have already tried at least one other cancer treatment. The goal is to see if the drug can shrink tumors or stop them from growing. This is not…
Matched conditions: HER-2 PROTEIN OVEREXPRESSION
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 16:01 UTC